The vascular endothelial growth factor (VEGF) is an important cancer marker and plays an crucial role in the tumor growth, invasion and metastasis [5], and gradually becomes a promising molecular target for the therapy of advanced NSCLC. Here, VEGFA is linked to non-small cell lung carcinoma.